Safety of the extension of use of galacto-oligosaccharides as a Novel food pursuant to Regulation (EU) 2015/2283. - Université de Lille Accéder directement au contenu
Article Dans Une Revue EFSA Journal Année : 2021

Safety of the extension of use of galacto-oligosaccharides as a Novel food pursuant to Regulation (EU) 2015/2283.

J. Castenmiller
  • Fonction : Auteur
S. de Henauw
  • Fonction : Auteur
K. I. Hirsch-Ernst
  • Fonction : Auteur
A. Maciuk
  • Fonction : Auteur
I. Mangelsdorf
  • Fonction : Auteur
H. J. Mcardle
  • Fonction : Auteur
A. Naska
  • Fonction : Auteur
C. Pelaez
  • Fonction : Auteur
K. Pentieva
  • Fonction : Auteur
A. Siani
  • Fonction : Auteur
F. Thies
  • Fonction : Auteur
S. Tsabouri
  • Fonction : Auteur
M. Vinceti
  • Fonction : Auteur
F. Cubadda
  • Fonction : Auteur
T. Frenzel
  • Fonction : Auteur
M. Heinonen
  • Fonction : Auteur
R. Marchelli
  • Fonction : Auteur
M. Neuhäuser-Berthold
  • Fonction : Auteur
M. Poulsen
  • Fonction : Auteur
M. Prieto Maradona
  • Fonction : Auteur
J. R. Schlatter
  • Fonction : Auteur
H. van Loveren
  • Fonction : Auteur
P. Colombo
  • Fonction : Auteur
H. K. Knutsen
  • Fonction : Auteur

Résumé

Following a request from the European Commission, the EFSA Panel on Nutrition, Novel Foods and FoodAllergens (NDA) was asked to deliver an opinion on the extension of use of galacto-oligosaccharides(GOS) as a novel food (NF) pursuant to Regulation (EU) 2015/2283. The NF is a syrup containing≥57%w/w GOS (w/w dry matter), consisting of different galactosyl residues linked to a terminal glucose by ab-glycosidic bond and also containing lactose and the constituent monomers of lactose (galactose andglucose). The NF is already authorised and included in the Union list of NFs and is produced according tothe same production process. This application is limited to an assessment of the extension of use as afood ingredient in dairy confectionary, cheese and processed cheese, butter and spreads. There is a10–30% increase in total GOS intake from the requested extension of use compared to the currentlyauthorised uses at the highest 95th percentile. It is noted that the total intake at the highest mean(8.7–22.0 g/day) is below the adequate intake (AI) of 25 g/day for dietaryfibre set to ensure a normallaxation in adults, while the highest 95th percentile (27.2–41.6 g/day) is higher than the AI. When themaximum use as a food supplement is added to the highest 95th percentile combined intake from allproposed and authorised food categories a total intake up to 58 g GOS/day is estimated. This highestintake level would exceed the AI for dietaryfibre; however, no tolerable upper intake level for dietaryfibrehas been set and only transient gastrointestinal symptoms may be related to high intake offibre. ThePanel concludes that the NF, that is composed of≥57% GOS dry matter, lactose and related saccharides,is safe under the proposed extension of use
Fichier principal
Vignette du fichier
EFSA Journal - 2021 - - Safety of the extension of use of galacto‐oligosaccharides as a Novel food pursuant to Regulation .pdf (1.38 Mo) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-04481931 , version 1 (28-02-2024)

Licence

Paternité - Pas de modifications

Identifiants

Citer

Dominique Turck, T. Bohn, J. Castenmiller, S. de Henauw, K. I. Hirsch-Ernst, et al.. Safety of the extension of use of galacto-oligosaccharides as a Novel food pursuant to Regulation (EU) 2015/2283.. EFSA Journal, 2021, EFSA Journal, 19, pp.e06844. ⟨10.2903/j.efsa.2021.6844⟩. ⟨hal-04481931⟩

Collections

RIIP UNIV-LILLE
4 Consultations
2 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More